Augmedics vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
Augmedics makes the xvision Spine System, the first FDA-cleared AR headset for spine surgery; completed 10,000th AR-guided surgery in April 2025; launched next-gen X2 headset with FDA 510(k) clearance.
About
Augmedics is a medical device and augmented reality company that develops surgical navigation technology for spine procedures. Founded in 2014 and headquartered in Chicago, Augmedics pioneered the application of see-through augmented reality in the operating room with its flagship xvision Spine System — the first FDA-cleared AR navigation device for spinal surgery in the United States. The system allows surgeons to visualize a patient''s anatomy in real time as if they have x-ray vision, overlaying CT-derived 3D models onto their direct view of the surgical field without looking away to a separate monitor.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.